Loading...
Bafna Pharmaceuticals Limited — Tamoxifen Export Profile: Buyers & Destinations
Loading...
Indian Pharmaceutical Exporter · #12 for Tamoxifen · $48.3K export value · DGFT Verified
Bafna Pharmaceuticals Limited is the #12 Indian exporter of Tamoxifen with $48.3K in export value and 5 verified shipments. Bafna Pharmaceuticals Limited holds a 0.3% market share in Tamoxifen exports across 1 countries. The company exports 6 pharmaceutical products worth $2.4M across 6 therapeutic categories.
| Country | Value | Shipments | Share |
|---|---|---|---|
| UNITED STATES | $6.3M | 160 | 53.9% |
| UNITED KINGDOM | $1.6M | 61 | 14.1% |
| BELGIUM | $1.2M | 79 | 10.0% |
| THAILAND | $1.0M | 43 | 8.8% |
| GERMANY | $900.0K | 18 | 7.8% |
| SRI LANKA | $120.5K | 13 | 1.0% |
| MALTA | $105.6K | 11 | 0.9% |
| SOUTH AFRICA | $74.4K | 10 | 0.6% |
| LITHUANIA | $71.9K | 8 | 0.6% |
| VENEZUELA | $52.9K | 5 | 0.5% |
India exports Tamoxifen to 104 countries. The top destination is UNITED STATES (53.9%), followed by UNITED KINGDOM and BELGIUM.
| Buyer | Country | Value | Orders |
|---|---|---|---|
| AUROBINDO PHARMA USA., INC, | UNITED STATES | $2.5M | 85 |
| ALIUD PHARMA GMBH | GERMANY | $1.3M | 25 |
| AUROBINDO PHARMA USA INC | UNITED STATES | $1.2M | 25 |
| AUROLOGISTICS LLC, (AUROBINDO PHARM | UNITED STATES | $1.1M | 23 |
| BELLS HEALTHCARE | UNITED KINGDOM | $416.4K | 13 |
India exported $11.0M worth of Tamoxifen through 3,139 shipments from 220 suppliers to 104 countries, serving 377 buyers globally. Bafna Pharmaceuticals Limited contributes $48.3K to this total, accounting for 0.3% of India's Tamoxifen exports.
Bafna Pharmaceuticals Limited's average Tamoxifen shipment value is $9.7K per consignment, based on 5 shipments totaling $48.3K.
Bafna Pharmaceuticals Limited ranks #12 among 220 Indian Tamoxifen exporters with a 0.3% market share. The top 3 exporters are EUGIA PHARMA SPECIALITIES LIMITED ($6.7M), GRANULES INDIA LIMITED ($1.3M), BDR PHARMACEUTICALS INTERNATIONAL PRIVATE LIMITED ($830.4K). Bafna Pharmaceuticals Limited processed 5 shipments to 1 destination countries.
What Bafna Pharmaceuticals Limited must comply with to export Tamoxifen to its top destination countries
Approval Process
ANDA (Abbreviated New Drug Application) for generics. Indian manufacturing site must pass FDA pre-approval inspection. Drug Master File (DMF) required for APIs.
Timeline: 10–18 months for ANDA approval
GMP & Export Requirements
FDA cGMP compliance (21 CFR 210/211); facility inspection by FDA
Drug Listing with FDA; Export Certificate from CDSCO India; Import Alert screening via FDA PREDICT system
Note: Subject to FDA Import Alerts. Open Form 483 observations can block all exports from a facility.
Approval Process
Exporters ranked immediately above and below #12 by export value
| # | Supplier | Export Value | Shipments | Countries | Avg/Shipment |
|---|---|---|---|---|---|
| 10 | KWALITY PHARMACEUTICALS LIMITED | $73.7K | 7 | 1 | $10.5K |
| 11 | FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED | $50.5K | 5 | 1 | $10.1K |
| 12 | BAFNA PHARMACEUTICALS LIMITED ★ | $48.3K | 5 | 1 | $9.7K |
| 13 | NEON LABORATORIES LIMITED | $42.0K | 25 | 3 | $1.7K |
| Port | Shipments | % Share |
|---|---|---|
| SAHAR AIR CARGO ACC (INBOM4) | 776 | 24.7% |
| DELHI AIR CARGO ACC (INDEL4) | 638 | 20.3% |
| SAHAR AIR | 541 | 17.2% |
| DELHI AIR | 301 | 9.6% |
| Bombay Air | 177 | 5.6% |
| Delhi Air | 91 | 2.9% |
| HYDERABAD AIR | 80 | 2.5% |
| Bombay Air Cargo | 57 | 1.8% |
Bafna Pharmaceuticals Limited exports 6 products worth $2.4M. Beyond Tamoxifen, top products include Sitagliptin, Terbinafine, Chlorpheniramine, Mebendazole, Terbutaline. View the complete Bafna Pharmaceuticals Limited profile for full portfolio analysis.
Latest developments and market context
Detailed market intelligence for Tamoxifen — including regulatory updates, trade policy changes, and competitive landscape analysis — will be available in an upcoming update. This section will feature AI-researched insights from verified industry sources, government notifications, and market reports.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Access shipment-level details, pricing data, buyer connections, and competitive analysis for Bafna Pharmaceuticals Limited's Tamoxifen exports. TransData Nexus provides verified Indian Customs (DGFT) data trusted by pharmaceutical trade professionals worldwide.
Bafna Pharmaceuticals Limited
Full Company Profile →
6 products · $2.4M total trade · 6 categories
| WOCKHARDT UK LIMITED | UNITED KINGDOM | $409.8K | 9 |
| TILLOMED LABORATORIES LIMITED | UNITED KINGDOM | $404.1K | 14 |
| AUROBINDO PHARMA USA., INC | UNITED STATES | $351.2K | 8 |
| AUROLOGISTICS LLC AUROBINDO PHARM | UNITED STATES | $300.0K | 6 |
| AUROBINDO PHARMA USA.INC.,. | UNITED STATES | $200.0K | 4 |
India's Tamoxifen is purchased by 377 buyers worldwide. The top buyer is AUROBINDO PHARMA USA., INC, (UNITED STATES), followed by ALIUD PHARMA GMBH and AUROBINDO PHARMA USA INC.
Post-Brexit UK Marketing Authorisation via national procedure. Separate from EU approval since January 2021.
Timeline: 12–15 months
GMP & Export Requirements
UK GMP compliance; MHRA inspection of manufacturing site
Manufacturer Import Authorisation (MIA) held by UK importer; Qualified Person (QP) batch release
Note: Post-Brexit: EU GMP certificates no longer automatically valid in UK. Separate MHRA recognition required.
Regulatory information is provided for general reference based on publicly available guidelines. Requirements vary by formulation, dosage form, and therapeutic classification. Exporters should consult qualified regulatory affairs professionals for case-specific guidance.
| 14 |
| CAPLIN POINT LABORATORIES LIMITED |
| $41.1K |
| 7 |
| 3 |
| $5.9K |
Bafna Pharmaceuticals Limited ranks #12 among 220 Indian Tamoxifen exporters. Average shipment value of $9.7K compared to the market average of $50.0K. The closest competitors by value are KWALITY PHARMACEUTICALS LIMITED and FLAGSHIP BIOTECH INTERNATIONAL PRIVATE LIMITED.
Verify manufacturer licensing and export certifications with the official agencies above.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
Global Coverage
Exports to 104+ countries, 377+ buyers
Expert-Reviewed
Analyzed by pharmaceutical trade specialists
Access shipment-level records, pricing trends, and buyer contacts for Bafna Pharmaceuticals Limited.
Request DemoView Pricing →Trade data sourced from Indian Customs (DGFT) export shipment records. Values represent FOB export value in USD. Market share calculated relative to total Indian pharmaceutical exports for Tamoxifen. For current shipment-level data, contact TransData Nexus.